R. Klooster

A. Twijnstra, J. Verschuuren, S. M. van der Maarel, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade

Miguel Ángel Martínez, A. Mondal, T. Logtenberg, 2021, Nature Communications.

A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade

Miguel Ángel Martínez, A. Mondal, T. Logtenberg, 2021, Nature communications.

Selection and characterization of KDEL-specific VHH antibody fragments and their application in the study of ER resident protein expression.

Quint le Duc, C. Verrips, R. Roovers, 2009, Journal of immunological methods.

In Search for Biomarkers of Aging : A Proteomics Approach

R. Klooster, 2006 .

Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2

Daniel G. Miller, S. Tapscott, M. Bamshad, 2012, Nature Genetics.

Phosphorylation of p42/44MAPK by Various Signal Transduction Pathways Activates Cytosolic Phospholipase A2to Variable Degrees*

J. Boonstra, A. Verkleij, R. Klooster, 2001, The Journal of Biological Chemistry.

Long-lasting treatment effect of rituximab in MuSK myasthenia

J. Verschuuren, R. Rojas-García, I. Illa, 2012, Neurology.

Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.

J. G. van Dijk, A. Vincent, J. Verschuuren, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Selection and characterization of llama single domain antibodies against N-terminal huntingtin

G. van Ommen, J. D. den Dunnen, W. V. van Roon-Mom, 2014, Neurological Sciences.

Self‐regulated alternative splicing at the AHNAK locus

A. Morrée, R. Frants, A. Impagliazzo, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis

J. Veldink, J. Verschuuren, P. Damme, 2016, Neuromuscular Disorders.

SATB1, genomic instability and Gleason grading constitute a novel risk score for prostate cancer

C. Thorns, S. Freitag-Wolf, G. Auer, 2021, Scientific Reports.

Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4

J. Gilbert, J. Stajich, R. Frants, 2007, Neurology.

820 MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T cells

P. Loo, A. Mondal, T. Logtenberg, 2020, Journal for ImmunoTherapy of Cancer.

The clinical DELTA-P score accurately predicts small cell lung cancer in the Lambert-Eaton myasthenic syndrome

A. Vincent, P. Wirtz, J. Verschuuren, 2010 .

A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy

Daniel G. Miller, S. Tapscott, J. Dauwerse, 2010, Science.

Selection and characterization of KDEL-specific VHH antibody fragments and their application in the study of ER resident protein expression.

Quint le Duc, R. Klooster, P. Verheesen, 2009, Journal of immunological methods.

Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity

J. Verschuuren, I. Illa, K. Straasheijm, 2016, Journal of Neuroimmunology.

Facioscapulohumeral muscular dystrophy region gene 1 (FRG1) is a dynamic RNA-associated and actin bundling protein

R. Klooster, Peter L Jones, T. Jones, 2011 .